Metformin treatment shows benefit in gestational diabetes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      Overall, the trial's primary outcome, a composite ofinsulin initiation or a fasting glucose level >= 5.1mmol/L (92 mg/dL) at gestation weeks 32 or 38, did notdiffer between women with gestational diabetes randomlyassigned to either placebo or metformin. Latest News AT EASD 2023 HAMBURG - Initiating metformin treatment at gestationaldiabetes diagnosis was associated with improved glycemiccontrol and reduced gestational weight gain, according tothe results of a randomized, placebo-controlled trial. [Extracted from the article]
    • Abstract:
      Copyright of OB-GYN News is the property of Frontline Medical Communications and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)